Dr. Soror Sharifpoor is the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP) within the Ted Rogers Centre for Heart Research. She joined TBEP in 2017 and has been involved in the fostering and implementation of sustainable research plans, successful partnerships, scientific and clinical translation strategies, an entrepreneurial ecosystem, and multifaceted training programs in the cardiovascular health sector.
She is also the co-founder of Entrepreneurship for Cardiovascular Health Opportunities (ECHO), where she has been facilitating research translation and start-up creation. Launched in 2018, ECHO is a national entrepreneurship training and mentorship program for innovators of cardiovascular technologies.
Dr. Sharifpoor has over 15 years of academic and industrial experience in the fields of biomaterials, biomedical engineering, and regenerative medicine, specializing in cardiovascular and soft tissue research and innovation. From 2016 to 2020, she served as the Chief Executive Officer of Polumiros Inc., a biomaterials start-up company that she co-founded. While at Polumiros, she led the development of a novel immunomodulatory polymer platform technology and was pivotal to fundraising as well as regulatory and commercialization strategy development. Prior to joining Polumiros, she served as an associate research engineer at Interface Biologics Inc., where she was involved in the commercialization of innovative biomaterials for improving the efficacy of medical devices and targeted drug delivery.
Dr. Sharifpoor received her Bachelors at the University of Toronto (Engineering Science – Biomedical Engineering major), her Masters at Queen’s University (Chemical Engineering) and her PhD at the University of Toronto (Biomedical Engineering). She has been the recipient of several fellowships and awards, most notably FACIT’s Ernsting Entrepreneurship Award and the Norman F. Moody Award for Academic Excellence.